Imke Satzger

Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma

David Liu, Bastian Schilling, Derek Liu et al. · Nature Medicine · 2019 · 1K citations · Full text

The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network

Caroline Voskens, Simone M. Goldinger, Carmen Loquai et al. · PLoS ONE · 2013 · 463 citations · Full text

Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity

Ralf Gutzmer, Anika Koop, Friedegund Meier et al. · European Journal of Cancer · 2017 · 216 citations

Autoimmune Disease, Ipilimumab-triggered Autoimmunity, Immunology +10

MicroRNA‐15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma

Imke Satzger, A. Mattern, Uta Kuettler et al. · International Journal of Cancer · 2009 · 199 citations · Full text

Pathology, Malignant Melanoma, Cancer Biology +18

Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomas

Imke Satzger, T. Schaefer, Uta Kuettler et al. · British Journal of Cancer · 2008 · 163 citations · Full text

Human Mucosal Melanomas, Immunology, Kit Gene Mutation +16